Exploiting the reprogramming technology, Schöndorf and colleagues generated two control iPSC lines, four GBA1 PD lines, and two GD lines, and even genetically corrected two of the GBA1 PD lines [49]. This evidence concerns the gene GBA1 and Parkinson disease.